Paediatric Hepatic International Tumour Trial

Brief summary (registry, in English)

The PHITT trial is an over-arching study for patients with Hepatoblastoma (HB) and Hepatocellular Carcinoma (HCC). This trial will use a risk-adapted approach to the treatment of children diagnosed with HB. Children with HCC will be included as a separate cohort.

What you commit to

• Study type: Interventional · Phase 3
• Planned participants: 450
• From 24 Aug 2017 to the primary completion date, 31 Dec 2026
• 112 sites in 14 countries
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: - to 30 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (112)

Sites in registry order. Pick your city on the disease page to sort them by distance.